Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Schizophrenia, Bristol Myers Squibb and FDA
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the debilitating mental disorder in over seven decades.
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
7h
Wall Street Breakfast Podcast: Bristol-Myers Wins FDA Nod For Novel Antipsychotic
Bristol-Myers wins FDA nod for novel antipsychotic. DirecTV, Dish close in on merger to form largest US pay-TV service: ...
8h
Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco
Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Pleads not guilty
Promotes watch collection
'Harry Potter' star dies
World's oldest cheese found
Killer gets life sentence
Stadiums to serve as shelters
Targeted Black residents?
50/50 ball ownership suit
Producing doc on Diddy
Boxes to distribute Narcan
Ending password-sharing
Urgent safety alert for 737s
Heads to US-Mexico border
Fake Biden robocalls fine
More executives leave
On Secret Service failures
Arrives in Luxembourg
NIH finds misconduct
NC board removes 747K
Chinese submarine sank
WI duplicate ballot flap
Rose announces retirement
Capital goods orders up
Military recruiting rebounds
Feedback